Evaxion to host Q2 business update, financial results call and webcast
EVAX•EVX-05 to be discussed
EVX-05, its newly added off-the-shelf glioblastoma vaccine program, will be among the topics discussed.
Conference call and webcast scheduled for Aug. 20
Evaxion will host a conference call and webcast on Aug. 20 at 8:30 a.m. ET to present its Q2 2026 business update and financial results.
Participants can register for the call and join the webcast using the links provided in the source notice.
